SCHEMBL7679755

SCHEMBL7679755

O=C(Nc1ccccc1)c1c[nH]c2c(c1=O)CCC2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 8/20 0.56
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
HPGD P15428 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
MAPT P10636 2/20 0.44
ALDH1A1 P00352 1/20 0.43
TP53 P04637 3/20 0.43
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42
GABRA1 P14867 1/20 0.41
GABRB1 P18505 1/20 0.41
GABRA5 P31644 1/20 0.41
GABRA3 P34903 1/20 0.41
GABRA2 P47869 1/20 0.41
GABRB2 P47870 1/20 0.41
GABRA4 P48169 1/20 0.41
GABRA6 Q16445 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7454498 0.97 CFTR (0.56) CFTRMEN1KMT2AHPGDTDP1
SCHEMBL7682505 0.85 MAOB (0.46) CFTRMEN1KMT2AHPGDTP53
SCHEMBL7446235 0.84 TP53 (0.52) CFTRMEN1KMT2AMAPTTP53
SCHEMBL7680828 0.84 MAPT (0.61) MEN1KMT2ATDP1MAPTALDH1A1
SCHEMBL7449715 0.83 TP53 (0.48) CFTRMEN1KMT2AHPGDTDP1
SCHEMBL6162613 0.83 ALDH1A1 (0.51) MEN1KMT2AHPGDALDH1A1TP53
SCHEMBL7679353 0.82 TP53 (0.66) MEN1KMT2AMAPTALDH1A1TP53
SCHEMBL7676086 0.82 LMNA (0.55) CFTRMEN1KMT2AMAPTALDH1A1
SCHEMBL7446323 0.81 MAPT (0.64) HPGDTDP1MAPTALDH1A1TP53
SCHEMBL6163600 0.81 NPC1 (0.53) MEN1KMT2ATP53KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448259-B1 CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GAMMA AMINOBUTYRIC ACID BINDING SITE, THE BENZODIAZEPINE RECEPTOR; ANXIETY, SLEEP AND SEIZURE DISORDERS SEDATIVE, ANXIOLYTIC AND ANTICONVULSANT ACTIVITY NEUROGEN CORPORATION 2002-09-10 US disclosed
US-6194427-B1 BRAIN DISORDERS; PSYCHOLOGICAL DISORDERS; SLEEP DISORDERS; ANTICONVULSANTS NEUROGEN CORPORATION 2001-02-27 US disclosed